Cellular and molecular biology of the inflamed liver

Current Opinion in Gastroenterology

Volumn 13, Issue 3, 1997, Pages 175-185

  Crawford, James M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; L SELECTIN;

ACUTE PHASE RESPONSE; APOPTOSIS; ARTICLE; BILE; CELL ADHESION; CELL INFILTRATION; CHOLESTASIS; CYTOLOGY; ENDOTHELIUM CELL; ENDOTOXEMIA; HEPATITIS; HUMAN; KUPFFER CELL; LIVER CELL; LIVER NECROSIS; LIVER PARENCHYMA; LIVER SINUSOID; MACROPHAGE; MOLECULAR BIOLOGY; NEUTROPHIL; SEPSIS; STELLATE CELL; T LYMPHOCYTE;

EID: 0030986192     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199705000-00002     Document Type: Article

References (117)

1. Burgstahler AD, Nathanson MH: NO modulates the apicolateral • cytoskeleton of isolated hepatocytes by a PKC-dependent, cGMP-independent mechanism. Am J Physiol 1995, 269:G789-G799. Although NO induces smooth muscle relaxation, in isolated hepatocyte couplets NO was shown to potentiate rather than inhibit apical cytoskeletal contraction. This stimulation occured via activation of protein kinase C, rather than by a cGMP mechanism. These observations suggest a new role for NO: to activate protein kinase C.
2. Beuers U, Throckmorton DC, Anderson MS, Isales CM, Thasler W, Kullak-Ublick G-A, Sauter G, Koebe HG, Paumgartner G, Boyer JL: Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology 1996, 110:1553-1563.
3. 2+ signaling in rat bile duct epithelia. Am J Physiol 1996, 271:G86-G96.
4. 1 signals in both the stimulated cell and nearby noncontiguous cells. This signaling was mediated by release of ATP or other nucleotides into the extracellular space. This study implicates paracrine signaling for the epithelial cells of the liver.
5. Bouscarel B, Ceryak S, Gettys TW, Fromm H, Noonan F: Alteration of cAMP-mediated hormonal responsiveness by bile acids in cells of nonhepatic origin. Am J Physiol 1995, 286:G908-G916.
6. Stravitz RT, Rao YP, Vlahcevic ZR, Gurley EC, Jarvis WD, Hylemon PB: • Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7α-hydroxylase. Am J Physiol 1996, 271:G293-G303. The signaling mechanisms for bile acid regulation of the rate-limiting enzyme for bile acid biosynthesis from cholesterol, cholesterol 7α-hydroxylase, were examined. Bile acids were found to activate intracellular protein kinase C, resulting in its sequential redistribution and downregulation of both calcium-dependent and -independent isoforms of this kinase. This study indicates that bile acids can act as ligands to stimulate intracellular signaling pathways for nuclear gene transcriptional regulation.
7. Vlahcevic ZR, Jairath SK, Heuman DM, Stravitz RT, Hylemon PB, Avadhani NG, Pandak WM: Transcriptional regulation of hepatic sterol 27-hydroxylase by bile acids. Am J Physiol 1996, 270:G646-G652.
8. Barr VA, Scott LJ, Hubbard AL: Immunoadsorption of hepatic vesicles • carrying newly synthesized dipeptidyl peptidase IV and polymeric IgA receptor. J Biol Chem 1995, 270:27834-27844. This group has previously shown that apical plasma membrane proteins must route through the basolateral plasma membrane before retrieval and delivery to the apical pole of the hepatocyte. In this study, dipeptidyl peptidase IV is shown to be endocytosed from the basolateral membrane in vesicles that are distinct from the clathrin-coated vesicles containing polymeric IgA receptor. Transcytosis of these two proteins from basolateral early endosomes to the subapical region appears to occur via a single transcytotic pathway. The mechanisms for sorting and regulation of the transcytotic pathway are under continued investigation.
9. Chowdhury NR, Hays RM, Bommineni VR, Franki N, Chowdhury JR, Wu • CH, Wu GY: Microtubular disruption prolongs the expression of human bilirubin-uridinediphosphoglucuronate-glucuronosyltransferase-1 gene transferred into Gunn rat livers. J Biol Chem 1996, 271:2341-2346. The Gunn rat, deficient in the hepatocellular enzyme necessary for bilirubin conjugation, was used to evaluate gene-targeting to the liver. The appropriate DNA was complexed with galactose-terminated (asialo-) glycoprotein-polylysine conjugates, so as to take advantage of receptor-mediated endocytosis of the asialoglycoprotein. Disruption of hepatocellular microtubule function with colchicine led to marked persistence of the DNA in the liver, suggesting a new noninvasive method for prolonging the effect of liver-targeted gene therapy.
10. Crawford JM: The role of vesicle-mediated transport pathways in hepatocellular bile secretion. Semin Liver Dis 1996, 16:169-190.
11. Henley JR, McNiven MA: Association of a dynamin-like protein with the • Golgi apparatus in mammalian cells. J Cell Biol 1996, 133:761-775. Dynamins are a family of 100-kd GTPases that are thought to facilitate the formation of endocytic vesicles, and hence promote intracellular vesicular traffic. This study documents that a dynamin-like protein associates with the Golgi apparatus and may therefore play a role in remodeling and trafficking of vesicles in multiple sites within the cell. The role of these proteins in hepatocyte vesicular trafficking is under investigation.
12. Marks DL, LaRusso NF, McNiven MA: Isolation of the microtubulevesicle motor kinesin from rat liver: selective inhibition by cholestatic bile acids. Gastroenterology 1995, 108:824-833.
13. Hamm-Alvarez SF, Wei XH, Berndt N, Runnegar M: Protein phosphatases independently regulate vesicle movement and microtubule subpopulations in hepatocytes. Am J Physiol 1996, 271:C929-C943.
14. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996, 271:518-520.
15. 344->Ser). J Lipid Res 1995, 36:2329-2343.
16. Ishibashi S, Schwarz M, Frykman PK, Herz J, Russell DW: Disruption of cholesterol 7α-hydroxylase gene in mice: 1. Postnatal lethality reversed by bile acid and vitamin supplementation. J Biol Chem 1996, 271:18017-18023.
17. Schwarz M, Lund EG, Setchell KDR, Kayden HJ, Zerwekh JE, Björkhem I, Herz J, Russell DW: Disruption of cholesterol 7α-hydroxylase gene in mice: 2. Bile acid deficiency is overcome by induction of oxysterol 7α-hydroxylase. J Biol Chem 1996, 271:18024-18031.
18. Welch CL, Xia YR, Shechter I, Farese R, Mehrabian M, Mehdizadeh S, Warden CH, Lusis AJ: Genetic regulation of cholesterol homeostasis: chromosomal organization of candidate genes. J Lipid Res 1996, 37:1406-1421.
19. Kuipers F, Van Ree JM, Hofker MH, Wolters H, Veld GI, Havinga R, Vonk RJ, Princen HMG, Havekes LM: Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver. Hepatology 1996, 24:241-247.
20. Robins SJ, Fasulo JM, Pritzker CR, Patton GM: Hepatic transport and • secretion of unesterified cholesterol in the rat is traced by the plant sterol, sitostanol. J Lipid Res 1996, 37:15-21. Unesterified cholesterol exchanges between circulating lipoproteins and the hepatocyte basolateral plasma membrane, whereas cholesteryl esters can only be liberated after hepatocellular endocytosis and degradation of lipoproteins. The plant sterol sitostanol can be used as a nonmetabolizable analogue of free cholesterol. Sitostanol, incorporated into phosphatidylcholine liposomes, was taken up from the perfusate of isolated rat livers and appeared rapidly in bile; biliary secretion was dependent on bile salt secretion. The rapid transit from plasma-to-bile paralleled that of free cholesterol. These studies suggest that sitostanol can be used as a physiologic analogue of unesterified cholesterol to trace the transport of sterols through the liver.
21. Weisiger RA: When is a carrier not a membrane carrier? The cytoplas•• mic transport of amphipathic molecules. Hepatology 1996, 24:1288-1295. In addressing the trafficking of small amphipathic organic molecules through the liver, most attention focuses on the function and molecular regulation of protein transporters in the basolateral and canalicular plasma membrane. This review addresses research demonstrating that diffusion of these molecules through the cytoplasm also may constitute a rate-limiting process for cellular transport and metabolism. Moreover, inherited storage diseases may seriously disrupt normal cytoplasmic transport mechanisms.
22. Luxon BA: Inhibition of binding to fatty acid binding protein reduces the intracellular transport of fatty acids. Am J Physiol 1996, 271:G113-G120.
23. Monaghan G, Ryan M, Seddon R, Hume R, Burchell B: Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 1996, 347:578-581.
24. Takikawa H, Sugiyama Y, Fernandez-Checa JC, Kuhlenkamp J, Ookhtens M, Kaplowitz N: Evidence that interference with binding to hepatic cytosol binders can inhibit bile acid excretion in rats. Hepatology 1996, 23:1642-1649.
25. Crawford JM, Möckel G-M, Crawford AR, Hagen SJ, Hatch VC, Barnes S, Godleski JJ, Carey MC: Imaging biliary lipid secretion in the rat: ultrastructural evidence for vesiculation of the hepatocyte canalicular membrane. J Lipid Res 1995, 36:2147-2163.
26. Mayer R, Kartenbeck J, Büchler M, Jedlitschky G, Leier I, Keppler D: Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transportdeficient mutant hepatocytes. J Cell Biol 1995, 131:137-150.
27. Nies AT, Gatmaitan Z, Arias IM: ATP-dependent phosphatidyl-choline translocation in rat liver canalicular plasma membrane vesicles. J Lipid Res 1996, 37:1125-1136.
28. Puglielli L, Rigotti A, Amigo L, Nun̄ez L, Greco AV, Santos MJ, Nervi F: Modulation of intrahepatic cholesterol trafficking: evidence by in vivo antisense treatment for the involvement of sterol carrier protein-2 in newly synthesized cholesterol transport into rat bile. Biochem J 1996, 317:681-687.
29. Yano M, Marinelli RA, Roberts SK, Balan V, Pham L, Tarara JE, DE Groen PC, La Russo NF: Rat hepatocytes transport water mainly via a nonchannel-mediated pathway. J Biol Chem 1996, 271:6702-6707.
30. Moseley RH: Liver: editorial review. Curr Opin Gastroenterol 1997, 13:171-174.
31. Peters M: Actions of cytokines on the immune response and viral • interactions: an overview. Hepatology 1996, 23:909-916. An excellent recent review of the general actions of cytokines in inflammatory diseases, and the mechanisms by which viral infiections can evade cytokine-mediated host defenses.
32. Chisari FV: Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis. Curr Top Microbiol Immunol 1996, 206:149-173.
33. Koziel MJ: Immunology of viral hepatitis. Am J Med 1996, 100:98-109.
34. Yamada T, Hoshino M, Hayakawa T, Kamiya Y, Ohhara H, Mizuno K, • Yamada H, Nakazawa T, Inagaki T, Uchida A, et al.: Bile secretion in rats with indomethacin-induced intestinal inflammation. Am J Physiol 1996, 270:G804-G812. Subacute intestinal inflammation was induced by subcutaneous injection of high-dose indomethacin. Endotoxin levels in the blood increased, and there were significant changes in hepatic bile formation. This model may be useful in exploring the interplay between the intestine and liver during hepatic inflammatory injury.
35. Deutschman CS, Haber BA, Andrejko K, Cressman DE, Harrison R, •• Elenko E, Taub R: Increased expression of cytokine-induced neutrophil chemoattractant in septic rat liver. Am J Physiol 1996, 271:R593-R600. Sprague-Dawley rats were made septic by cecal ligation and puncture. Hepatocytes and Kupffer cells exhibited a time-dependent increase in CINC, with TNF-α-induced binding of NF-κB to the nuclear promotor region of CINC implicated as the mechanism. This finding supports the concept of hepatocytes acting as immunomodulatory cells.
36. Spitzer JJ: Bacterial endotoxin effects on carbohydrate utilization and transport Bioch Soc Trans 1995, 23:998-1002.
37. Titheradge MA, Knowles RG, Smith FS, Horton RA, Ceppi ED: Mechanism of inhibition of hepatic gluconeogenesis by bacterial endotoxin: a role for nitric oxide. Biochem Soc Trans 1995, 23:1002-1008.
38. Kellum JA, Bellomo R, Kramer DJ, Pinsky MR: Hepatic anion flux during acute endotoxemia. J Appl Physiol 1995, 78:2212-2217.
39. Tiggelman AMB, Boers W, Lintherst C, Brand HS, Sala M, Chamuleau RAF: Interleukin-6 production by human liver (myo)fibroblasts in culture: evidence for a regulatory role of LPS, IL-1β and TNFα J Hepatol 1995, 23:295-306.
40. McGuinness OP, Lacy DB, Ejiofor J, Bagby GG: Hepatic release of tumor necrosis factor in the endotoxin-treated conscious dog. Shock 1996, 5:344-348.
41. Sarphie TG, D'Souza NB, Deaciuc IV: Kupffer cell inactivation prevents lipopolysaccharide-induced structural changes in the rat liver sinusoid: an electron-microscopic study. Hepatology 1996, 23:788-796.
42. Suzuki S, Nakamura S, Serizawa A, Sakaguchi T, Konno H, Muro H, Kosugi I, Baba S: Role of Kupffer cells and the spleen in modulation of endotoxin-induced liver injury after partial hepatectomy. Hepatology 1996, 24:219-225.
43. B receptors on the liver dysfunction and injury caused by endotoxaemia in the rat. Br J Pharmacol 1996, 119:479-486.
44. Mallat A, Lotersztajn S: Multiple hepatic functions of endothelin-1: physiopathological relevance. J Hepatol 1996, 25:405-413.
45. Bohlinger I, Leist M, Gantner F, Angermuller S, Tiegs G, Wendel A: DNA fragmentation in mouse organs during endotoxic shock. Am J Pathol 1996, 149:1381-1393.
46. Mochida S, Ohno A, Arai M, Tamatani T, Miyasaka M, Fujiwara K: Role of adhesion molecules in the development of massive hepatic necrosis in rats. Hepatology 1996, 23:320-328.
47. Vollmar B, Richter S, Menger MD: Leukocyte stasis in hepatic sinu•• soids. Am J Physiol 1996, 270:G798-G803. Leukocyte trafficking through the hepatic microvasculature was studied with intravital fluorescence microscopy, using a model of ischemia-reperfusion. Hepatic reperfusion after ischemia was characterized by perfusion failure of individual sinusoids and a significant increase in sinusoidal leukostasis. However, most sinusoids with stagnant leukocytes were still perfused. Thus, sinusoidal leukostasis per se does not appear to be sufficient to induce perfusion failure ("no-reflow") after ischemia-reperfusion of the liver.
48. Hellerbrand C, Wang SC, Tsukamoto H, Brenner DA, Rippe RA: • Expression of intercellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology 1996, 24:670-676. A differential polymerase chain reaction technique was used to demonstrate that perisinusoidal stellate (Ito) cells increase their expression of ICAM-1 following 1 week of bile duct ligation. Thus, the stellate cells may have a direct role in the transmigration of neutrophils from the hepatic sinusoid during inflammation.
49. Jaeschke H, Essani NA, Fisher MA, Vonderfecht SL, Farhood A, Smith CW: Release of soluble intercelular adhesion molecule 1 into bile and serum in murine endotoxin shock. Hepatology 1996, 23:530-536.
50. Panes J, Perry MA, Anderson DC, Muzykantov VR, Carden DL, Miyasaka M, Granger DN: Portal hypertension enhances endotoxin-induced intercellular adhesion molecule 1 up-regulation in the rat. Gastroenterology 1996, 110:866-874.
51. Van Oosten N, Van de Bilt E, De Vries HE, Van Berkel TJC, Kuiper J: Vascular adhesion molecule-1 and intercellular adhesion molecule-1 expression on rat liver cells after lipopolysaccharide administration in vivo. Hepatology 1995, 22:1538-1546.
52. Spitzer JA, Zhang P, Mayer AMS: Functional characterization of peripheral circulating and liver recruited neutrophils in endotoxic rats. J Leukocyte Biol 1994, 56:166-173.
53. Maher JJ: Rat hepatocytes and Kupffer cells interact to produce inter• leukin-8 (CINC) in the setting of ethanol. Am J Physiol 1995, 269:G518-G523. The mechanism of ethanol-induced hepatic inflammation was examined by determining whether short-term ethanol exposure stimulated production of rat interleukin-8 (CINC) by hepatocytes or Kupffer cells. There was no direct stimulation by ethanol, but cytokines and endotoxin induced CINC production by both cell types. as did conditioned medium from ethanol-pretreated hepatocytes. The mechanism of ethanol-induced neutrophil infiltration into the liver is therefore likely to be indirect, involving ethanol oxidation and communication between hepatocytes and Kupffer cells.
54. Colletti LM, Kunkel SL, Walz A, Burdick MD, Kunkel RG, Wilke CA, Strieter RM: The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 1996, 23:506-514.
55. Hisama N, Yamaguchi Y, Ishiko T, Miyanari N, Ichiguchi O, Goto M, Mon K, • Watanabe K, Kawamura K, Tsurufuji S, Ogawa M: Kupffer cell production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion injury in rats. Hepatology 1996, 24:1193-1198. Using an ischemia-reperfusion model of rat liver injury, Kupffer cells were shown to play a major role in the expression of CINC. Kupffer cell release of CINC is proposed to play an important role in early neutrophil infiltratioin into the liver following ischemia-reperfusion.
56. Spitzer JA, Zhang P: Hepatic cellular interactions in endotoxaemia and sepsis. Biochem Soc Trans 1995, 23:993-998.
57. Sewerynek E, Melchiorri D, Reiter RJ, Ortiz GG, Lewinski A: Lipopolysaccharide-induced hepatotoxicity is inhibited by the antioxidant melatonin. Eur J Pharmacol Environ Toxicol Pharmacol 1995, 293:327-334.
58. Spolarics Z, Stein DS, Garcia ZC: Endotoxin stimulates hydrogen peroxide detoxifying activity in rat hepatic endothelial cells. Hepatology 1996, 24:691-696.
59. DeLamatre JG, Schilleci JT, Hanson LH: Influence of dietary fat on the effect of endotoxin on murine hepatic peroxisomes. Hepatology 1996, 24:592-595.
60. Shi J, Fujieda H, Kokubo Y, Wake K: Apoptosis of neutrophils and their elimination by Kupffer cells in rat liver. Hepatology 1996, 24:1256-1263.
61. Asumendi A, Alvarez A, Martinez I, Smedsrod B, Vidal-Vanaclocha F: Hepatic sinusoidal endothelium heterogeneity with respect to mannose receptor activity is interleukin-1 dependent. Hepatology 1996, 23:1521-1529.
62. Baumann H, Wang YP, Morella KK, Lai CF, Dams H, Hilton DJ, Hawley RG, Mackiewicz A: Complex of the soluble IL-11 receptor and IL-11 acts as IL-6-type cytokine in hepatic and nonhepatic cells. J Immunol 1996, 157:284-290.
63. Ballmer PE, Imoberdorf R, Zbären J: Immunohistochemical demonstration of interleukin-1β induced changes in acute-phase proteins and albumin in rat liver. Acta Histochem 1995, 97:281-289.
64. Qian DL, Brosnan JT: Administration of Escherichia coli endotoxin to rat increases liver mass and hepatocyte volume in vivo. Biochem J 1996, 313:479-486.
65. Shattuck KE, Grinnell CD, Goldman AS, Rassin DK: The acute effects of TNF-α on the isolated perfused rat liver. J Invest Med 1996, 44:64-69.
66. Hatano E, Tanaka A, Iwata S, Satoh S, Kitai T, Tsunekawa S, Inomoto T, Shinohara H, Chance B, Yamaoka Y: Induction of endotoxin tolerance in transgenic mouse liver expressing creatine kinase. Hepatology 1996, 24:663-669.
67. Arai T, Hiromatsu K, Kobayashi N, Takano M, Ishida H, Nimura Y, Yoshikai Y: IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury. J Immunol 1995, 155:5743-5749.
68. Bour ES, Ward LK, Cornman GA, Isom HC: Tumor necrosis factor-induced apoptosis in hepatocytes in long-term culture. Am J Pathol 1996, 148:485-495.
69. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A: Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995, 146:1220-1234.
70. Fantuzzi G, Zheng H, Faggioni R, Benigni F, Ghezzi P, Sipe JD, Shaw AR, Dinarello CA: Effect of endotoxin in 11-1B-deficient mice. J Immunol 1996, 157:291-296.
71. Whiting JF, Green RM, Rosenbluth AB, Gollan JL: Tumor necrosis factor-α decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis. Hepatology 1995, 22:1273-1278.
72. +-ATPase also was decreased. Alterations of these transporters are thought to contribute to the cholestasis of sepsis and inflammation.
73. Moseley RH, Wang W, Takeda H, Lown K, Shick L, Ananthanarayanan M, •• Suchy FJ: Effect of endotoxin on bile acid transport in rat liver: a potential model for sepsis-associated cholestasis. Am J Physiol 1996, 271:G137-G146. Bile acid transport was measured in basolateral and canalicular rat liver plasma membrane vesicles isolated from control and endotoxin or TNF-α-treated animals. Sodium-dependent basolateral bile acid transport was greatly reduced, as was ATP-dependent and membrane potential-dependent canalicular transport The mRNA levels and immunoblot antigenic content of the putative membrane transporters were similarly decreased. Impaired bile acid transport at the sinusoidal and canalicular membrane domains by these and other mediators of the inflammatory response may account for sepsis-associated cholestasis.
74. Roelofsen H, Schoemaker B, Bakker C, Ottenhoff R, Jansen PLM, Elferink •• RPJO: Impaired hepatocanalicular organic anion transport in endotoxemic rats. Am J Physiol 1995, 269:G427-G434. Rats injected intravenously with endotoxin were shown to exhibit decreased canalicular secretion capacity for an organic anion transported by the canalicular multiple organic anion transporter. The decrease was predominantly a loss in secretion capacity, as stimulation of the allosteric regulator protein kinase C could not restore the canalicular transport capacity of endotoxemic hepatocytes.
75. Kartenbeck J, Leuschner U, Mayer R, Keppler D: Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 1996, 23:1061-1066.
76. Moseley RH: Sepsis-associated jaundice: comments. Hepatology 1996, 24:969-970.
77. Bellezzo JM, Britton RS, Bacon BR, Fox ES: LPS-mediated NF-κB activation in rat Kupffer cells can be induced independently of CD14. Am J Physiol 1996, 270:G956-G961.
78. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U: Control of 1κB-α proteolysis by site-specific signal-induced phosphorylation. Science 1995, 267:1485-1488.
79. Tracy TF Jr, Dillon P, Fox ES, Minnick K, Vogler C: The inflammatory response in pediatric biliary disease: macrophage phenotype and distribution. J Pediatr Surg 1996, 31:121-126.
80. Spolarics Z: Endotoxin stimulates gene expression of ROS-eliminating pathways in rat hepatic endothelial and Kupffer cells. Am J Physiol 1996, 270:G660-G666.
81. Weidenbach H, Beckh K, Burger M, Schricker T, Georgieff M, Adler G: Effects of selective phosphodiesterase 3 inhibition in the perfused liver of the rat after endotoxin treatment. Br J Pharmacol 1996, 118:790-796.
82. Ghermay AP, Brady S, Havel RJ, Harris HW, Rapp JH: Sepsis increases endocytosis of endotoxin into hepatocytes. Surgery 1996, 120:389-394.
83. Mimura Y, Sakisaka S, Harada M, Sata M, Tanikawa K: Role of hepatocytes in disposition of lipopolysaccharide in rats. Gastroenterology 1995, 109:1969-1976.
84. Hardardottir I, Grunfeld C, Feingold KR: Effects of endotoxin on lipid metabolism. Biochem Soc Trans 1995, 23:1013-1018.
85. Pajkrt D, Doran JE, Koster F, Lerch PG, Arnet B, van der Poll T, ten Cate JW, Van Deventer SJH: Anti inflammatory effects of reconstituted highdensity lipoprotein during human endotoxemia. J Exp Med 1996, 184:1601-1608.
86. Nussler AK, Beger HG, Liu ZZ, Billiar TR: Nitric oxide, hepatocytes and inflammation. Res Immunol 1995, 146:671-677.
87. Dugas B, Debre P, Moncada S: Nitric oxide, a vital poison inside t he immune and inflammatory network. Res Immunol 1996, 146:664-670.
88. De Vera ME, Kim YM, Wong HR, Wang Q, Billiar TR, Geller DA: Heat shock response inhibits cytokine-inducible nitric oxide synthase expression in rat hepatocytes. Hepatology 1996, 24:1238-1245.
89. Rockey DC, Chung JJ: Regulation of inducible nitric oxide synthase in • hepatic sinusoidal endothelial cells. Am J Physiol 1996, 271:G260-G267. The complex interplay between proinflammatory cytokines in regulation of sinusoidal endothelial cell iNOS was examined. Regulation was accomplished both by modulation of gene transcription and by enzyme inactivation.
90. Wagner JG, Ganey PE, Roth RA: Nitric oxide is not involved in hepatocyte killing by neutrophils activated by N-formyl-methionyl-leucylphenylalanine or phorbol myristate acetate in vitro. Hepatology 1996, 23:803-810.
91. Kitade H, Sakitani K, Inoue K, Masu Y, Kawada N, Hiramatsu Y, Kamiyama • Y, Okumura T, Ito S: Interleukin 1β markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in Kupffer cells. Hepatology 1996, 23:797-802. Stimulation of NO release by hepatocytes and Kupffer cells was examined. Interleukin-1β alone was capable of stimulating NO release by hepatocytes. TNF-α and interleukin-6 were capable of modulating the interleukin-1β effect but could not stimulate hepatocytes directly. None of the cytokines tested stimulated NO production by Kupffer cells. This study demonstrates that some cytokines may have direct and immediate effects on hepatocytes.
92. Martin-Sanz P, Diaz-guerra MJM, Casado M, Boscá L: Bacterial lipopolysaccharide antagonizes transforming growth factor β1-induced apoptosis in primary cultures of hepatocytes. Hepatology 1996, 23:1200-1207.
93. Kuo PC, Abe KY, Schroeder RA: Interleukin-1-induced nitric oxide • production modulates glutathione synthesis in cultured rat hepatocytes. Am J Physiol 1996, 271:C851-C862. Interleukin-1 stimulation of NO synthesis is shown to promote hepatocyte glutathione synthesis through a mechanism that is dependent on transcriptional regulation of the rate limiting enzyme for glutathione synthesis. In the setting of oxidative stress, therefore, hepatocyte synthesis of NO may be protective.
94. De Vera ME, Geller DA, Billiar TR: Hepatic inducible nitric oxide synthase: regulation and function. Biochem Soc Trans 1995, 23:1008-1013.
95. Pastor CM, Losser M-R, Payen D: Nitric oxide donor prevents hepatic • and systemic perfusion decrease induced by endotoxin in anesthetized rabbits. Hepatology 1995, 22:1547-1553. Linsidomine was used as a NO donor and was beneficial in maintaining systemic and hepatic perfusion in the setting of endotoxemia. However, NO release was insufficient to fully maintain hepatic perfusion.
96. Swain MG, Maric M: Tumor necrosis factor-a stimulates adrenal glucocorticoid secretion in cholestatic rats. Am J Physiol 1996, 270:G987-G991.
97. +-dependent bile acid uptake, and downregulation of the transcription and posttranscriptional processing of the relevant ntcp transporter. The selective decline in ntcp is proposed to represent a protective feedback mechanism in cholestasis to diminish uptake of potentially hepatotoxic bile acids.
98. Aouad K, Calmus Y, Nordlinger B, Myara A, Weill B, Poupon R: Immunosuppressive effects of endotoxins and bile acids in vivo in the rat Eur J Clin Invest 1996, 26:45-48.
99. Tjandra K, Kubes P, Rioux K, Swain MG: Endogenous glucocorticoids inhibit neutrophil recruitment to inflammatory sites in cholestatic rats. Am J Physiol 1996, 270:G821-G825.
100. Swain MG, Tjandra K, Kanwar S, Kubes P: Neutrophil adhesion is impaired in a rat model of cholestasis. Gastroenterology 1995, 109:923-932.
101. Deaciuc IV, Alappat JM, McDonough KH, D'Souza NB: Interleukin-6 and tumor necrosis factor-α clearance and metabolism in vivo and by the isolated, perfused liver in the rat: effect of acute alcohol administration. Alcohol Clin Exp Res 1996, 20:293-301.
102. Knittel T, Janneck T, Muller L, Fellmer P, Ramadori G: Transforming • growth factor B1 -regulated gene expression of Ito cells. Hepatology 1996, 24:352-360. In this paper. TGF-β 1 is shown to be a potent stimulant of perisinusoidal stellate (Ito) cell fibrogenesis.
103. Tiggelman AMB, Boers W, Linthorst C, Sala M, Chamuleau RAF: Collagen synthesis by human liver (myo)fibroblasts in culture: evidence for a regulatory role of IL-1β, IL-4, TGFβand IFN gamma. J Hepatol 1995, 23:307-317.
104. Deaciuc IV, Spitzer JJ: Hepatic sinusoidal endothelial cell in alcoholemia and endotoxemia. Alcohol Clin Exp Res 1996, 20:607-614.
105. Crawford JM: Graft-versus-host disease of the liver. In Graft-versus-Host Disease. Edited by Ferrara JLM. Deeg J, Burakotf S. New York: Marcel Dekker; 1996:315-336.
106. Paradis K, Le ONL, Russo P, St-Cyr M, Fournier H, Bu DW: Characterization and response to interleukin 1 and tumor necrosis factor of immortalized murine biliary epithelial cells. Gastroenterology 1995, 109:1308-1315.
107. Leon MP, Bassendine MF, Wilson JL, Ali S, Thick M, Kirby JA: Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ T cells. Hepatology 1996, 24:561-567.
108. Mano Y, Ishii M, Okamoto H, Igarashi T, Kobayashi K, Toyota T: Effect of tumor necrosis factor α on intrahepatic bile duct epithelial cells in rat liver. Hepatology 1996, 23:1602-1607.
109. Adams DH, Hubscher SG, Fisher NC, Williams A, Robinson M: Expression of E-selectin and E-selectin ligands in human liver inflammation. Hepatology 1996, 24:533-538.
110. Shindo M, Mullin GE, Braun-Elwert L, Bergasa NV, Jones EA, James SP: Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB). Clin Exp Immunol 1996, 105:254-259.
111. Krams SM, Cao S, Hayashi M, Villanueva JC, Martinez OM: Elevations in IFN-gamma, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30. Clin Immunol Immunopathol 1996, 80:311-320.
112. Kuroki T, Seki S, Kawakita N, Nakatani K, Hisa T, Kitada T, Sakaguchi H: Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch [A] 1996, 429:119-129.
113. Tsai SL, Lai MY, Chen DS: Analysis of rearranged T cell receptor (TCR) Vβ transcripts in livers of primary biliary cirrhosis: preferential Vβ usage suggests antigen-driven selection. Clin Exp Immunol 1996, 103:99-104.
114. Yasoshima M, Nakanuma Y, Tsuneyama K, Van de Water J, Gershwin ME: Immunohistochemical analysis of adhesion molecules in the micro environment of portal tracts in relation to aberrant expression of PDC-E2 and HLA-DR on the bile ducts in primary biliary cirrhosis. J Pathol 1995, 175:319-325.
115. Mayo MJ, Combes B, Jenkins RN: T-cell receptor VB gene utilization in primary biliary cirrhosis. Hepatology 1996, 24:1148-1155.
116. Howell CD, De Victor D, Li J, Stephens J, Giorno RC: Liver T cell subsets and adhesion molecules in murine graft-versus-host disease. Bone Marrow Transplant 1995, 16:139-145.
117. Ueno Y, Phillips JO, Ludwig J, Lichtman SN, LaRusso NF: Development • and characterization of a rodent model of immune-mediated cholangitis. Proc Natl Acad Sci U S A 1996, 93:216-220. Cholangitis was induced in rats by immunization with highly purified bile duct epithelial cells (cholangiocytes). Recipient animals developed histological evidence of nonsuppurative cholangitis without inflammation in other organs. Cholangiograms showed distortion and tortuosity of the entire intrahepatic biliary ductal system. This unique rodent model of experimental cholangitis may prove useful in exploring the mechanisms by which the immune system targets and damages cholangiocytes.